Waters is focusing on the UltraPerformance Liquid Chromatography (UPLC) as it helps reduces acetonitrile consumption by at least 70 per cent without compromising productivity and performance.
Its well-known brand, Acquity UPLC System, allows scientists to perform required analysis, such as quality assurance and quality control tests, using less resource than HPLC. Because the system operates with a wider velocity range, higher flow rates, and greater backpressures, UPLC uses significantly less solvent, including acetonitrile. The result is the ability to maintain or improve lab productivity and performance, with reduced costs and reduced external pressures associated with the current acetonitrile shortages.
"The time for Acquity UPLC adoption has never been clearer," said Rohit Khanna, vice president of Global Marketing for the Waters Division. "Laboratory-dependent businesses and government agencies around the world are facing difficult decisions because there is simply not enough acetonitrile available to efficiently run their labs using traditional liquid chromatography technology. As these organizations evaluate their options, the innovations behind UPLC technology provide the best solution to today's crisis and safeguarding against future risk."